Virtu Financial’s Theseus Pharmaceuticals, Inc. Common Stock THRX Stock Holding History

Virtu Financial’s Portfolio THRX Stock Details THRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-26,467	Closed	-$107K	–	2360
2023 Q4	$107K	Buy	+26,467	New	+$80.8K	0.01%	1020

Virtu Financial's THRX Position: Q1 2024 in Review

Virtu Financial sold out of Theseus Pharmaceuticals, Inc. Common Stock (THRX) in Q1 2024, closing a stake of 26,467 shares — an estimated $107K sold.

Virtu Financial first reported a position in THRX in Q4 2023 and held it in 1 quarter. The position peaked at $107K in Q4 2023. 1 fund tracked by Wall St. Rank holds THRX as of Q1 2024.

Virtu Financial reported no remaining Theseus Pharmaceuticals, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Virtu Financial sold 26,467 Theseus Pharmaceuticals, Inc. Common Stock shares in Q1 2024, an estimated $107K.
Virtu Financial first reported a position in Theseus Pharmaceuticals, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
Virtu Financial's Theseus Pharmaceuticals, Inc. Common Stock position peaked at $107K in Q4 2023.
1 fund tracked by Wall St. Rank held Theseus Pharmaceuticals, Inc. Common Stock as of Q1 2024.

Based on Virtu Financial's 13F filing for Q1 2024, filed 20 May 2024.